Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, ...

Rochester Emergency Veterinary Services is opening it's new hospital at 445 West Commercial St. in East Rochester on Friday ...

BioAegis' lead product is currently being studied in a 600-patient global Phase 2 trial for patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS). This project has been supported ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial hurdles and leadership changes.

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

AKBA's shares fell after announcing the pricing of its secondary issue of shares, which were at a discount to the previous closing price.

Ballinamallard manager Mark Stafford is looking for his side to be “more ruthless” in front of goal as they look to secure their NIFL Championship survival.

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

It also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trial to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant ...

The recent passing of Betsy Arakawa Hackman, wife of legendary actor Gene Hackman, has brought renewed attention to ...